Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Challenges and patenting strategies for Chinese herbal medicine. | Wang and Chan Chinese Medicine 2010 5 24 http content 5 1 24 CHINESE MEDICINE COMMENTARY Open Access Challenges and patenting strategies for Chinese herbal medicine Xinsheng Wang1 and Albert Wai-Kit Chan 2 Abstract Patents for Chinese herbal medicines can be difficult to obtain. When the active ingredients of an herbal formula are known danfang single herb prescriptions is better protected with quantified composition claims. When the active ingredients are unknown product by processing method of processing method of administration and new use claims are often powerful tools to distinguish a traditional danfang from the prior art Additional patents may also be filed continuously in the product development process Existing patents for fufang composite prescriptions are primarily drafted to protect traditional herbal formulations More efforts are needed to protect various herbal combinations and their multiple applications Introduction Keeping Chinese medicine formulae as trade secrets has led to some losses of knowledge and experience accumulated over generations. Drugs as well as dietary supplements are subject to regulations and disclosure requirements it has become increasingly difficult for CM practitioners to keep their prescriptions and treatment methods as trade secrets. In 1993 the Chinese government issued the Regulations on the Protection of Traditional Chinese Medicines which to this date provides administrative protection to certain prescriptions and manufacturing processes 1 . For developing new drugs and improved formulations many Chinese herbs are being studied by major pharmaceutical companies with modern technologies. These companies rely on patent to protect their intellectual properties. Due to vast philosophical differences between CM and Western medicine there are challenges in patent applications for CM-related products. The present article discusses some of the challenges and proposes solutions to these challenges. Discussion
